Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients
Open Access
- 7 April 2016
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 91 (7), 692-699
- https://doi.org/10.1002/ajh.24382
Abstract
Systemic mastocytosis is a rare heterogeneous myeloproliferative neoplasm characterized by abnormal proliferation and activation of mast cells. We describe a large multicentre series of 460 adult patients with systemic mastocytosis, with a diagnosis based on WHO 2008 criteria, in a “real‐life” setting of ten Italian centers with dedicated multidisciplinary programs. We included indolent forms with (n = 255) and without (n = 165) skin lesions, smouldering (n = 20), aggressive (n = 28), associated with other hematological diseases mastocytosis (n = 21) and mast cell leukemia (n = 1). This series was uniquely characterized by a substantial proportion of patients with low burden of neoplastic mast cells; notably, 38% of cases were diagnosed using only minor diagnostic criteria according to WHO 2008 classification, underlying the feasibility of early diagnosis where all diagnostic approaches are made available. This has particular clinical relevance for prevention of anaphylaxis manifestations, that were typically associated with indolent forms. In multivariate analysis, the most important features associated with shortened overall survival were disease subtype and age at diagnosis >60 years. Disease progression was correlated with mastocytosis subtype and thrombocytopenia. As many as 32% of patients with aggressive mastocytosis suffered from early evolution into acute leukemia. Overall, this study provides novel information about diagnostic approaches and current presentation of patients with SM and underlines the importance of networks and specialized centers to facilitate early diagnosis and prevent disease‐associated manifestations. Am. J. Hematol. 91:692–699, 2016.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (AGIMM AIRC Gruppo Italiano Malattie Mieloproliferative #1005)
This publication has 33 references indexed in Scilit:
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on MastocytosisAllergy, 2014
- Epidemiology of systemic mastocytosis in DenmarkBritish Journal of Haematology, 2014
- Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosisLaboratory Investigation, 2014
- Systemic mastocytosis in adults: 2013 update on diagnosis, risk stratification, and managementAmerican Journal of Hematology, 2013
- Indolent systemic mastocytosis without skin involvement vs. isolated bone marrow mastocytosisHaematologica, 2011
- Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosisHaematologica, 2010
- Prognosis in adult indolent systemic mastocytosis: A long-term study of the Spanish Network on Mastocytosis in a series of 145 patientsJournal of Allergy and Clinical Immunology, 2009
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsBlood, 2009
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response CriteriaEuropean Journal of Clinical Investigation, 2007
- Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)Cytometry Part B: Clinical Cytometry, 2004